TAA05 Cell Injection in the Treatment of Recurrent / Refractory Acute Myeloid Leukemia
Clinical trial NCT05017883 · UNKNOWN
Trial details
- NCT number
- NCT05017883
- Sponsor
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2023-10-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.